Project #72: Optogenetics to stimulate maturation of functional replacement beta cells from human stem cells
This grant funds research using optogenetics to mature stem cell-derived beta cells for improved type 1 diabetes therapy, supported by the Diabetes Research Connection.
Funder: Diabetes Research Connection
Due Dates: Rolling
Funding Amounts: Up to $75,000 per project; typically one-year duration.
Summary: Supports innovative, early-career research using optogenetics to mature stem cell-derived beta cells for type 1 diabetes therapy.
Key Information: Focused on early-career researchers; awards are donor-driven and peer-reviewed.
Description
This funding opportunity, offered by the Diabetes Research Connection (DRC), supports research projects that advance innovative approaches for type 1 diabetes (T1D). The highlighted project explores optogenetic techniques to precisely control the maturation of human stem cell-derived beta cells, aiming to overcome current barriers in developing fully functional, transplant-ready cells for T1D treatment. The DRC’s mission is to fund early-career scientists pursuing novel, peer-reviewed work that could transform prevention, cure, or management of T1D and its complications.
